TEL AVIV, Israel and WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology ...
To express ABCD1 complementary DNA (cDNA), the elivaldogene autotemcel (eli-cel) gene therapy, which contains autologous CD34+ cells transduced with Lenti-D lentiviral vector, uses a virally derived ...
Cerebral adrenoleukodystrophy is a severe form of X-linked adrenoleukodystrophy characterized by white-matter disease, loss of neurologic function, and early death. Elivaldogene autotemcel (eli-cel) ...
The only gene-editing therapy approved for beta-thalassaemia at present is Vertex Pharma's CRISPR-based Casgevy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results